CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 86 filers reported holding CRINETICS PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,461,736 | +133.7% | 116,400 | +41.6% | 0.00% | +200.0% |
| Q2 2023 | $1,481,244 | +13.4% | 82,200 | +1.1% | 0.00% | 0.0% |
| Q1 2023 | $1,305,678 | -21.4% | 81,300 | -10.5% | 0.00% | 0.0% |
| Q4 2022 | $1,661,640 | -3.8% | 90,800 | +3.2% | 0.00% | 0.0% |
| Q3 2022 | $1,728,000 | +5.3% | 88,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,641,000 | -5.0% | 88,000 | +11.8% | 0.00% | 0.0% |
| Q1 2022 | $1,727,000 | -14.4% | 78,700 | +10.8% | 0.00% | 0.0% |
| Q4 2021 | $2,017,000 | +93.2% | 71,000 | +43.1% | 0.00% | 0.0% |
| Q3 2021 | $1,044,000 | +11.7% | 49,600 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $935,000 | +62.6% | 49,600 | +31.9% | 0.00% | – |
| Q1 2021 | $575,000 | +12.5% | 37,600 | +3.9% | 0.00% | – |
| Q4 2020 | $511,000 | -9.9% | 36,200 | 0.0% | 0.00% | – |
| Q3 2020 | $567,000 | -10.6% | 36,200 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $634,000 | +129.7% | 36,200 | +92.6% | 0.00% | – |
| Q1 2020 | $276,000 | -38.5% | 18,800 | +5.0% | 0.00% | – |
| Q4 2019 | $449,000 | +66.9% | 17,900 | 0.0% | 0.00% | – |
| Q3 2019 | $269,000 | -40.0% | 17,900 | 0.0% | 0.00% | – |
| Q2 2019 | $448,000 | – | 17,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 623,819 | $11,336,501 | 9.41% |
| Finepoint Capital LP | 822,745 | $15,056 | 4.87% |
| Bain Capital Life Sciences Investors, LLC | 2,305,558 | $42,192 | 4.72% |
| Opaleye Management Inc. | 732,000 | $13,395,600 | 4.66% |
| 5AM Venture Management, LLC | 862,286 | $15,779,834 | 4.24% |
| SPHERA FUNDS MANAGEMENT LTD. | 671,644 | $12,291,085 | 2.64% |
| First Light Asset Management, LLC | 1,329,313 | $24,326,428 | 2.26% |
| BRAIDWELL LP | 3,469,674 | $63,495,034 | 2.13% |
| BVF INC/IL | 2,736,613 | $50,080,018 | 2.11% |
| Perceptive Advisors | 4,039,276 | $73,918,751 | 2.08% |